IP Library Granted Patent US 8,148,577
Granted Patent B2
US 8,148,577 · App. 12/763,722 · Granted Apr 3, 2012

Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,148,577
App. No.
12/763,722
Granted
Apr 3, 2012
Kind
B2
Abstract

Polyamine, polyamine/guanidino, and polyamine/biguanide compounds are disclosed. The compounds are useful as anti-cancer and anti-parasitic treatments. The compounds are also useful as inhibitors of the enzyme lysine-specific demethylase-1.

Claims (19)

1. A compound having the formula (I):

or a salt thereof, wherein:

n is an integer from 1 to 12;

m and p are independently an integer from 1 to 5;

q is 0 or 1;

each R 1 is independently selected from the group consisting of;

C 1 -C 8 substituted or unsubstituted alkyl, C 4 -C 15 substituted or unsubstituted cycloalkyl, C 3 -C 15 substituted or unsubstituted branched alkyl, C 6 -C 20 substituted or unsubstituted aryl, C 6 -C 20 substituted or unsubstituted heteroaryl, C 7 -C 24 substituted or unsubstituted aralkyl, and C 7 -C 24 substituted or unsubstituted heteroaralkyl and,

each R 2 is independently selected from hydrogen or a C 1 -C 8 substituted or unsubstituted alkyl.

2. The compound of claim 1 , wherein the compound is a compound listed in Table A.

3. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

4. A kit comprising the compound of claim 1 and instructions for use as an anticancer or antiparasitic agent.

5. A method of inhibiting a histone demethylase, comprising administering an amount of a compound of claim 1 , wherein the amount of the compound is sufficient to inhibit the histone demethylase by at least about 50%.

6. A method of treating a parasitic infection, comprising administering a compound of claim 1 in a therapeutically effective amount.

7. The method of claim 5 , wherein the enzyme is lysine-specific demethylase-1.

8. A compound of claim 1 , wherein the compound is

9. A pharmaceutical composition of claim 3 wherein the compound is

10. A kit of claim 4 wherein the compound is

11. A method of claim 5 wherein the compound is:

12. A method of claim 6 wherein the compound is:

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 26, 2012
From: WAYNE STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028643/0107 →